Breast Cancer
Advertisement
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Soft tumor environments can cause triple-negative breast cancer to spread more aggressively.
Patients ≥70 years of age were more likely to have a reduction in their palbociclib dosage.
Decreasing the at-home dose of dexamethasone before paclitaxel treatment may help reduce the incidence of infusion reactions.
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
For women with BRCA1 sequence variations, MRI surveillance is linked to lower breast cancer mortality.
A study found a "substantial deficit" of undiagnosed cancer cases during the COVID-19 pandemic.
Completing HBOT appears effective at reducing pain and fibrosis in patients with irradiated breast cancer.
A researcher is looking to prove that nebivolol, an FDA-approved drug for high blood pressure, is effective at treating TNBC.
Screening and new treatments have led to a US breast cancer mortality rate that is 58% lower than in it was in the mid-1970s.
The FDA recently approved a new combination therapy for the treatment of HR-positive, HER2-negative breast cancer.
CNS radiotherapy with pyrotinib and capecitabine improves CNS progression in breast cancer patients with brain metastases.
The Oncology Brothers talk with Paolo Tarantino, MD, about the TROPiCS-02 study presented at SABCS.
Will HER2CLIMB-02 study data impact the breast cancer landscape?
For patients with breast cancer, a regimen of epirubicin followed by adjuvant chemotherapy is associated with worse QOL.
Drs. Vishwas Paralkar and Sophia Gayle discuss CBX-15, a novel therapy for triple-negative breast cancer.
Dan Forche, CEO of PreludeDx, a leader in precision medicine for early-stage breast cancer, discusses DCISionRT.
Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey.
The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types.
The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.